AdComm Date Announcement
March 10, 2016
Jett Foundation is thrilled that the re-scheduled date to evaluate Sarepta Therapeutics potential Duchenne therapy, eteplirsen, has been filed on the federal register and set for April 25, 2016 at College Marriott Hotel Conference Center, Chesapeake Ballroom, 3501 University BLVD East, Hyattsville, MD 20783.
Jett Foundation will continue to work with the collaborative coalition of groups including Parent Project Muscular Dystrophy, Race to Yes, Duchenne Alliance, and the Center for Muscular Dystrophy at UCLA to prepare the entire Duchenne community for the Ad Comm. Please stay tuned at Race to Yes for more information and updates throughout the day.
To attend please register at with the Coalition here.